Skip to main content
Fig. 2 | BMC Gastroenterology

Fig. 2

From: Intestinal fatty acid binding protein is a disease biomarker in paediatric coeliac disease and Crohn’s disease

Fig. 2

Boxplots A plasma, B urinary iFABP concentrations in Controls and patients with Coeliac during GFD; C plasma, D urinary iFABP concentration in Controls and patients with Colitis and Crohn’s during exclusive enteral nutrition. Coeliac: coeliac disease, ND: newly diagnosed, Crohn’s: Crohn’s disease, Controls: healthy control, mo: month, GFD: gluten-free diet, EEN: exclusive enteral nutrition. Urinary iFABP measurements are expressed after urinary creatinine correction, a: p < 0.05 compared with Controls; b: p < 0.05 compared with ND Coeliac

Back to article page